Live Breaking News & Updates on Contract Research

Stay updated with breaking news from Contract research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Parexel Named "Best Contract Research Organization" at 17th Annual Vaccine Industry Excellence (ViE) Awards

Parexel Named "Best Contract Research Organization" at 17th Annual Vaccine Industry Excellence (ViE) Awards
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Washington , United-states , Lori-preuit-dorer , Amy-mckee , Anne-kasmar , Danaka-williams , Head-of-oncology-center , Instagram , Contract-research-organization , Facebook , World-vaccine-congress-on , Vie-award-for-best-contract-research-organization

Parexel Named "Best Contract Research Organization" at 17th Annual Vaccine Industry Excellence (ViE) Awards

Parexel Named "Best Contract Research Organization" at 17th Annual Vaccine Industry Excellence (ViE) Awards
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Washington , United-states , Amy-mckee , Lori-preuit-dorer , Anne-kasmar , Danaka-williams , Vie-award-for-best-contract-research-organization , Twitter , Facebook , Contract-research-organization , Head-of-oncology-center , Linkedin

Aclaris Therapeutics (NASDAQ:ACRS) Stock Rating Upgraded by StockNews.com

Aclaris Therapeutics (NASDAQ:ACRS) Stock Rating Upgraded by StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Blackstone-inc , Capital-partners , Nasdaq , Contract-research , Vanguard-group-inc , Cantor-fitzgerald , Aclaris-therapeutics-inc , Samlyn-capital , Aclaris-therapeutics , Free-report

Buy PI Industries; target of Rs 4600: Anand Rathi

Anand Rathi is bullish on PI Industries has recommended buy rating on the stock with a target price of Rs 4600 in its research report dated March 22, 2024. ....

India , Anand-rathi , Contract-research , Pi-industries , Manufacturing-services , Pi-industries , Guy , Recommendations ,

Aclaris Therapeutics (NASDAQ:ACRS) Stock Rating Upgraded by StockNews.com

Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Monday. Several other equities research analysts have also issued reports on ACRS. BTIG Research reissued a “neutral” rating on shares of Aclaris Therapeutics in a […] ....

Canada , United-states , Contract-research , Aclaris-therapeutics-company-profile , Wells-fargo-company , Royal-bank , Aclaris-therapeutics-inc , Cantor-fitzgerald , Aclaris-therapeutics , Get-free-report , Wells-fargo